Screener
Idexx Laboratories IDXX Contract Liabilities, Non-Current
Contract Liabilities, Non-Current at other companies
Other financials
Where this comes from
Reported directly by Idexx Laboratories in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.
The source filing: Idexx Laboratories’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:14 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000874716-26-000076
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Long-Term Liabilities: | ||
| Deferred income tax liabilities | 44,595 | 31,865 |
| Long-term debt, net of current portion | 299,854 | 374,842 |
| Long-term deferred revenue, net of current portion | 32,313 | 32,177 |
| Long-term operating lease liabilities, net of current portion | 98,747 | 101,151 |
| Other long-term liabilities | 54,034 | 56,527 |
| Total long-term liabilities | 529,543 | 596,562 |
| Total liabilities | 1,829,394 | 1,745,376 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Idexx Laboratories's contract liabilities, non-current?
- Idexx Laboratories (IDXX) reported contract liabilities, non-current of $32.31M in Q1 2026.
- How has Idexx Laboratories's contract liabilities, non-current changed year-over-year?
- Idexx Laboratories's contract liabilities, non-current increased by 20.5% year-over-year, from $26.82M to $32.31M.
- What is the long-term trend for Idexx Laboratories's contract liabilities, non-current?
- Over 5 years (2020 to 2025), Idexx Laboratories's contract liabilities, non-current has grown at a -7.0% compound annual growth rate (CAGR), from $46.16M to $32.18M.
Ask your AI about Idexx Laboratories's contract liabilities, non-current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude